Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

307
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
307
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

212
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A dual-engineered chondrocyte-targeting tetrahedral DNA-based nanoparticle for improved delivery of metformin and alleviation in osteoarthritis.

Biomaterials·2026
Same author

The feedback regulation between DREB2C and E3 ligases DEL1/DEL2 for balancing the initial growth and ABA signaling in Arabidopsis.

The New phytologist·2026
Same author

A QuantiFERON<sup>®</sup>-TB Gold Plus-Based Model for Predicting Latent Tuberculosis Infection in Patients with Diabetes.

Infection and drug resistance·2026
Same author

Intracellular logic computing with DNA tetrahedron processors enables precision cancer theranostics.

Signal transduction and targeted therapy·2026
Same author

A photo-responsive, fisetin-functionalized DNA nanocage for programmed therapy to accelerate early-stage wound healing in aged skin.

Biomaterials·2026
Same author

DNA framework-based nanomedicine platform: a triple-function strategy for treating periodontitis via antibacterial, anti-inflammatory, and osteogenesis-promoting activities.

International journal of oral science·2026

相关实验视频

Updated: Jun 10, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

多药耐药结核病的危险因素:一个预测模型研究.

Lianpeng Wu1,2, Xiaoxiao Cai3, Xiangao Jiang2,4

  • 1Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, The Ding Li Clinical College of Wenzhou Medical University, Wenzhou, China.

Frontiers in medicine
|October 14, 2024
PubMed
概括

农村居住,结核病再治疗,肺腔,高尿酸和低C反应蛋白是多抗药结核病 (MDR-TB) 的关键危险因素. 使用这些因素的预测模型显示出有希望的结果.

关键词:
耐药结核病的治疗方法多药耐药结核病是多种药物耐药的结核病.命名图形模型 命名图形模型预测价值是一个预测值.有关风险因素的风险因素.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.6K

相关实验视频

Last Updated: Jun 10, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.6K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.6K

科学领域:

  • 传染性疾病 传染性疾病
  • 肺部病理学 肺部病理学
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 耐药结核病 (DR-TB) 是一个重大的全球卫生挑战.
  • 耐多药结核病 (MDR-TB) 是一种更严重,更难治愈的结核病形式.
  • 识别MDR-TB的风险因素对于早期检测和干预至关重要.

研究的目的:

  • 调查已经被诊断患有DR-TB的患者中与MDR-TB发展相关的独立风险因素.
  • 开发和验证MDR-TB风险分层的预测模型.

主要方法:

  • 在2018年1月至2022年12月期间接受治疗的715名DR-TB患者的回顾性分析.
  • 多变量逻辑回归用于识别独立的风险因素.
  • 构建和验证一个名ogram预测模型.

主要成果:

  • 多耐药结核病的独立风险因素包括农村居住,结核病再治疗,肺腔存在,尿酸 (UA) ≥346μmol/L和C反应蛋白 (CRP) <37.3 mg/L.
  • 诺米克模型的AUC值为0.758 (培训) 和0.775 (验证).
  • 该模型显示了良好的校准和临床实用性.

结论:

  • 住院,结核病治疗史,肺腔,UA和CRP水平与MDR-TB有显著的关联.
  • 开发的诺莫格拉姆模型为预测DR-TB患者的MDR-TB风险提供了一个有希望的工具.